Cargando…

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study

BACKGROUND/AIMS: To assess the effects and safety of DA-9701 (Motilitone) in patients with constipation-type irritable bowel syndrome (IBS-C) which frequently accompany functional dyspepsia (FD). METHODS: FD and IBS-C were diagnosed based on the Rome III criteria. Randomized subjects were administer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju Yup, Kim, Nayoung, Yoon, Hyuk, Shin, Cheol Min, Park, Young Soo, Lee, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Neurogastroenterology and Motility 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978125/ https://www.ncbi.nlm.nih.gov/pubmed/35232894 http://dx.doi.org/10.5056/jnm20236

Ejemplares similares

DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia
por: Jin, Mirim, et al.
Publicado: (2018)

Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016)

The Evidence of DA-9701 on Bowel Motility
por: Wang, Mingjie, et al.
Publicado: (2017)

DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia
por: Kwon, Yong Sam, et al.
Publicado: (2013)

The Effect of DA-9701 in Opioid-induced Bowel Dysfunction of Guinea Pig
por: Hussain, Zahid, et al.
Publicado: (2016)

Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
por: Choi, Ji‐Hyun, et al.
Publicado: (2020)

Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia
por: Wang, Congzhen, et al.
Publicado: (2021)

Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015)

Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice
por: Ha, Changyoon, et al.
Publicado: (2021)

Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome - Are Both Diseases Mutually Exclusive?
por: Suzuki, Hidekazu, et al.
Publicado: (2011)

Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats
por: Lee, Sang Pyo, et al.
Publicado: (2017)

Effects of the New Prokinetic Agent DA-9701 Formulated With Corydalis Tuber and Pharbitis Seed in Patients With Minimal Change Esophagitis: A Bicenter, Randomized, Double Blind, Placebo-controlled Study
por: Park, Chan Hyuk, et al.
Publicado: (2014)

Nitrergic Pathway Is the Major Mechanism for the Effect of DA-9701 on the Rat Gastric Fundus Relaxation
por: Min, Yang Won, et al.
Publicado: (2014)

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
por: WANG, AnJiang, et al.
Publicado: (2008)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders
por: de Bortoli, Nicola, et al.
Publicado: (2018)

Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats
por: Kang, Je Wook, et al.
Publicado: (2016)

Effect of DA-9701 on Colorectal Distension-Induced Visceral Hypersensitivity in a Rat Model
por: Kim, Eun Ran, et al.
Publicado: (2014)

Functional Dyspepsia: Subtypes, Risk Factors, and Overlap with Irritable Bowel Syndrome in a Population of African Patients
por: Nwokediuko, Sylvester Chuks, et al.
Publicado: (2012)

Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine
por: Kountouras, Jannis, et al.
Publicado: (2019)

G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome
por: Kim, Han Gyeol, et al.
Publicado: (2012)

Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
por: Hamatani, Tatsuto, et al.
Publicado: (2020)

Impact of Shiftwork on Irritable Bowel Syndrome and Functional Dyspepsia
por: Kim, Hye In, et al.
Publicado: (2013)

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study
por: Shin, Dong Woo, et al.
Publicado: (2018)

The Effect of DA-9701 on 5-Hydroxytryptamine-Induced Contraction of Feline Esophageal Smooth Muscle Cells
por: Oh, Kyung Hoon, et al.
Publicado: (2014)

Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome
por: Kim, Seung Young, et al.
Publicado: (2018)

The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders
por: Kountouras, Jannis, et al.
Publicado: (2019)

Functional constipation masked as irritable bowel syndrome
por: Tosto, Monica, et al.
Publicado: (2020)

The Efficacy and Safety of GCWB104 (Flos Lonicera Extract) in Functional Dyspepsia: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study
por: Choi, Yonghoon, et al.
Publicado: (2020)

Overlap in Patients With Dyspepsia/Functional Dyspepsia
por: Fujiwara, Yasuhiro, et al.
Publicado: (2014)

Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome
por: Hori, Kazutoshi, et al.
Publicado: (2009)

Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?
por: Niknam, Ramin, et al.
Publicado: (2016)

Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Min, Yang Won, et al.
Publicado: (2015)

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
por: Eswaran, Shanti, et al.
Publicado: (2014)

Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
por: Patel, Sarah, et al.
Publicado: (2021)

Arsenic in Irritative Dyspepsia
Publicado: (1870)

Arsenic in Irritative Dyspepsia
Publicado: (1871)

Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
por: Enck, Paul, et al.
Publicado: (2016)

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
por: Seretis, C., et al.
Publicado: (2011)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome
por: Yao, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_crh4am7jh3b2m4ejhev3u6n1ut